Latest News

Those holding Erika Carmel-Tech Ltd ( TLV:ERKA ) shares would be relieved that the share price has rebounded 54% in the...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Asker Healthcare Group fair value estimate is kr111 Asker...

When you see that almost half of the companies in the Software industry in the Netherlands have price-to-sales ratios...

The Netcompany Group A/S ( CPH:NETC ) share price has done very well over the last month, posting an excellent gain of...

With a price-to-earnings (or "P/E") ratio of 11.9x PORR AG ( VIE:POS ) may be sending bullish signals at the moment...

The analysts might have been a bit too bullish on engcon AB (publ) ( STO:ENGCON B ), given that the company fell short...

The market seemed underwhelmed by last week's earnings announcement from Castellum AB (publ) ( STO:CAST ) despite the...

LG Innotek (KRX:011070) has had a great run on the share market with its stock up by a significant 50% over the last...

Sanofi's ( EPA:SAN ) recent earnings report didn't offer any surprises, with the shares unchanged over the last week...

HWA AG ( ETR:H9W ) shares have had a horrible month, losing 26% after a relatively good period beforehand. The drop...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

With the business potentially at an important milestone, we thought we'd take a closer look at Biovica International AB...

DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen ( ETR:DAM ) shareholders have had...

It's not a stretch to say that Dermapharm Holding SE's ( ETR:DMP ) price-to-earnings (or "P/E") ratio of 17x right now...

AUTO1 Group SE's ( ETR:AG1 ) price-to-sales (or "P/S") ratio of 0.9x may not look like an appealing investment...

Elekta AB (publ) ( STO:EKTA B ), might not be a large cap stock, but it received a lot of attention from a substantial...

EPR Properties (EPR) reported net profit margins of 22.2%, down from 26.8% a year earlier, as negative earnings growth and a significant one-off loss of $56.9 million weighed on the bottom line. Revenue is expected to rise at just 2.5% per year, well below the broader US market’s 10.3% forecast. In a challenging environment, investors are left weighing the current margin pressures and non-recurring losses against the stock’s valuation, which currently sits below intrinsic estimates by...

OPKO Health (OPK) remains unprofitable, with losses increasing at an annual rate of 25% over the past five years. Despite facing headwinds on the bottom line, the company is forecast to grow revenue at 4.1% annually, trailing the broader US market’s average growth rate of 10.3% per year. Investors are left to weigh persistent losses and slower top-line expansion against valuation indicators that highlight relative value versus peers and the stock’s current trading discount to estimated fair...

Champion Iron (ASX:CIA) posted a net profit margin of 7.3%, falling from 15.3% a year ago, while earnings have declined by 24.5% annually over the last five years. With forecast earnings growth of 8.06% per year and revenue projected to increase by 2.2% annually, both of which lag the broader market, the results highlight ongoing margin pressure and multi-year headwinds. This is occurring even as the share price sits below discounted cash flow fair value estimates. See our full analysis for...

Agnico Eagle Mines (NYSE:AEM) posted current net profit margins of 32.6%, notably higher than last year’s 12.9%, with year-over-year earnings growth coming in at an impressive 240.6% compared to its five-year average annual growth rate of 32.1%. Despite this surge in profitability, revenue is forecast to grow at just 2.5% per year, trailing the broader US market’s 10.3% annual projection. Earnings are expected to decline at a rate of -0.4% per year over the next three years. This mix of...

New Gold Inc. recently reported record third-quarter results, with revenue of US$462.5 million, net income of US$142.3 million, and significant production growth driven by the Rainy River mine. The company also repaid US$260 million of debt and emphasized a disciplined approach to acquisitions while prioritizing organic growth and shareholder value. With record free cash flow reported in the third quarter, we'll evaluate how this operational strength shapes New Gold's investment...

Itron (ITRI) posted a net profit margin of 11.1%, up from 8% last year, as EPS growth continues at a forecast pace of 14.2% per year. Shares look attractively valued, trading at a Price-to-Earnings ratio of 18.5x, which is below the peer average of 38.4x and the overall US electronic industry’s 25.7x. Last year’s earnings grew by 43.9%. With margins expanding and limited risk factors noted, the company’s market price of $108.99 remains well below a fair value estimate of $173.42. This...

Wondering if Interparfums is a bargain or overpriced right now? You are not alone, especially with so much buzz around its valuation lately. While the stock has declined by 8.8% over the past week and is down 30.5% year-to-date, it is still up an impressive 114.3% over five years. This keeps investors guessing about its future direction. Recent headlines have highlighted Interparfums' expansion in global markets and high-profile licensing agreements. These developments...

Aecon Group (TSX:ARE) is forecast to deliver standout annual earnings growth of 207.99% in the coming years, while revenue is expected to rise at 5.5% per year, outpacing the Canadian market’s 5% growth projection. The company has recently turned profitable, with net profit margins improving after posting positive results in the last year. This follows five years in which earnings fell by 26.4% per year. Investors are likely focusing on Aecon’s valuation, with shares trading at a low 0.4x...